Navigation Links
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
Date:4/22/2009

o increase between 30% and 40% from 2008 to the range from $16.6 million to $17.9 million.

    Highlights of Recent Developments
    -- Management has decided to start the construction of Inner Mongolia
       plant buildings on May 9, 2009 and to attempt to complete it by the end
       of 2009.
    -- In addition to the cost of land use rights and related expenses
       (approximately $32.6 million) which Liang Fang has paid, other
       components of the project are yet to be funded, including construction
       costs of approximately $17.5 million, costs associated with the various
       production lines estimated at approximately $33.6 million and working
       capital of approximately $7.3 million.
    -- The Company entered into an intellectual rights transfer contract with
       Beijing Yipuan Bio-Medical Technology Co., Ltd. in December 2008 to
       acquire the drug Yipubishan, a highly effective and stable octreotide
       acetate injection solution, In the first quarter of 2009, the Company
       has paid up $7.9 million as required in the transfer. The Company
       believes this could contribute $11.0 million to 2009's sale revenues
       with net margin of 75%.
    -- The Company announced two drugs entering into clinical testing of SFDA
       in 2008, Isosorbide Mononitrate sustained release tablet, a highly
       effective drug for the prevention and treatment of angina; and
       Laevo-Bambutero a Class 1 drug to treat asthma.
    -- Lotus obtained the patent, along with exclusive production rights for
       Laevo-Bambutero in China, through the technology transfer agreement
       with Dongguan Kaifa for a cash payment of $7.0 million and a 3% royalty
       on products sales. The Company has already paid $2.9 million to
       Dongguan Kaifa. The Company intends to market Laevo-Bambutero as a
       better alternative to Bambutero for the treatment of asthma, since it
       uses an integra
'/>"/>
SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , ... July 01, 2015 , ... ... and rehabilitation clinics throughout New York and New Jersey, acquired South Bay Sports ... its portfolio of state-of-the-art clinics. At this most recent member of the Professional ...
(Date:6/30/2015)... Simi Valley, California (PRWEB) , ... June 30, ... ... quarter of the year, it has proven its continuing growth as a Master ... , On June 17th, the Simi Valley Chamber of Commerce Ambassadors headed by ...
(Date:6/30/2015)... ... , ... America is in a health crisis. Today, 4 out of 5 ... Why? , The answer is simple and is at the core of every disease ... treated over one million patients and, for the first time ever, gives readers and ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Ticket Down is a reliable source for last ... This legendary band has been packing stadiums across North America in conjunction with their 2015 ... they have the energy of a band in their twenties. Some of the most ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier ... Introduction to Hyperbaric Medicine Course. Clinicians from WCA partnering hospitals across the country, ... , Wound care and hyperbaric medicine education and training is something that ...
Breaking Medicine News(10 mins):Health News:Professional Physical Therapy Acquires Copiague’s South Bay Sports & Physical Therapy, P.C. 2Health News:1Heart Caregiver Services® Simi Valley Grand Opening 2Health News:1Heart Caregiver Services® Simi Valley Grand Opening 3Health News:1Heart Caregiver Services® Simi Valley Grand Opening 4Health News:12 Easy-To-Follow Steps to Transform Body, Mind and Spirit 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3
... University of Pennsylvania,s Abramson Cancer Center have discovered a ... immune system to destroy the cancer,s scaffolding. The strategy ... advanced pancreatic cancer, several of whose tumors shrank substantially. ... way in which they uncovered them -- could lead ...
... , THURSDAY, March 24 (HealthDay News) -- ... significantly shrink pancreatic tumors by targeting the tissue surrounding ... relies on an experimental antibody that sparks the patient,s ... holds tumors together. Although testing has so far ...
... health, but 24.6% of these are not based on any ... Unit at Baza Hospital (Granada), published in the journal BMC ... in primary and secondary school text books in order to ... we classified them into three categories messages with a ...
... Unit in Southampton, UK, have presented a new study ... addition to clinical risk factors (CRFs) and bone mineral ... fracture prediction models. The research findings were presented today ... Valencia, Spain. Using results from the Hertfordshire Cohort ...
... - is just as beneficial as real acupuncture for ... a study from Karolinska Institutet and Linkping University in ... for nausea, felt significant more nausea than patients in ... not to come from the traditional acupuncture method, but ...
... Helena Johansson, Research fellow at the Centre for Bone ... Dr. Maria-Belen Zanchetta, Research fellow at the Instituto de ... the winners of the 2011 ESCEO-AMGEN Fellowship. ... Aspects of Osteoporosis and Osteoarthritis (ESCEO) with support from ...
Cached Medicine News:Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 2Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 3Health News:Novel Treatment for Pancreatic Cancer Under Study 2Health News:Novel Treatment for Pancreatic Cancer Under Study 3Health News:Around 25 percent of health messages in Spanish text books are not based on scientific evidence 2Health News:Acupuncture is equally effective with simulated needles 2
(Date:6/30/2015)...  Ardelyx, Inc. (NASDAQ: ARDX ), a clinical-stage ... today announced that the Company will host its inaugural ... 1:00 pm EDT in New York City ... team will present an overview of the Company,s pipeline ... Phase 2b clinical trials for the treatment of patients ...
(Date:6/30/2015)... Fla. , June 30, 2015  July 4 th ... declaration of independence, and the spirit and people behind it. ... Foundation has partnered with USA Medical ... help increase funding for programs that empower independence for our ... country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... WAYNE, Pa. , June 30, 2015 ... ("Egalet"), a fully integrated specialty pharmaceutical company ... pain treatments, today announced top-line results from ... study of Egalet-002, an abuse-deterrent, extended-release, oral ... for the management of pain severe enough ...
Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... Targeting Pro-Inflammatory,Protein -, GAITHERSBURG, Md., April 18, ... publication of preclinical,study data demonstrating a role ... nuclear DNA-binding protein, in the pathology,of systemic ... or lupus) and rheumatoid arthritis. Data to ...
... RIDGE, N.J., April 19, 2007 /PRNewswire-FirstCall/ --,VioQuest ... focused on acquiring, developing and,commercializing targeted cancer ... VQD- 002, a direct inhibitor of Akt,activation ... tumors.,Pre-clinical data was presented in a poster ...
Cached Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: